How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer

被引：6
作者：
Ragnhammar, P
Blomgren, H
机构：
[1] Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm
来源：
MEDICAL ONCOLOGY | 1995年 / 12卷 / 03期
关键词：
5-fluorouracil; colorectal carcinoma;
D O I：
10.1007/BF01571196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：187 / 201
页数：15
相关论文
共 143 条
[1]   TREATMENT OF ADVANCED COLORECTAL-CANCER [J].
ABBRUZZESE, JL ;
LEVIN, B .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1989, 3 (01) :135-153
[2]  
ALLEGRA C, 1988, EXPANDING ROLE FOLAT
[3]   A RANDOMIZED PHASE-I AND PHASE-II STUDY OF SHORT-TERM INFUSION OF HIGH-DOSE FLUOROURACIL WITH OR WITHOUT N-(PHOSPHONACETYL)-L-ASPARTIC ACID IN PATIENTS WITH ADVANCED PANCREATIC AND COLORECTAL CANCERS [J].
ARDALAN, B ;
SINGH, G ;
SILBERMAN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) :1053-1058
[4]  
ASCHELE C, 1992, CANCER RES, V52, P1855
[5]   MODIFICATION OF RIBONUCLEOTIDE AND DEOXYRIBONUCLEOTIDE METABOLISM IN INTERFERON-TREATED HUMAN B-LYMPHOBLASTOID CELLS [J].
BARANKIEWICZ, J ;
KAPLINSKY, C ;
COHEN, A .
JOURNAL OF INTERFERON RESEARCH, 1986, 6 (06) :717-727
[6]  
BEDIKIAN AY, 1981, CANCER TREAT REP, V65, P747
[7]  
BERGER SH, 1988, MOL PHARMACOL, V34, P480
[8]  
BERGER SH, 1985, MOL PHARMACOL, V28, P461
[9]  
BROHEE D, 1991, MED ONCOL TUMOR PHAR, V8, P271
[10]   DOSE-DEPENDENT LEUCOVORIN EFFICACY WITH AN INTERMITTENT HIGH-DOSE 5-FLUOROURACIL SCHEDULE [J].
BRUCKNER, HW ;
GLASS, LL ;
CHESSER, MR .
CANCER INVESTIGATION, 1990, 8 (3-4) :321-326
12345678910